RACK1 inhibits ferroptosis of cervical cancer by enhancing SLC7A11 core-fucosylation

Receiver for Activated C Kinase 1 (RACK1) is a highly conserved scaffold protein that can assemble multiple kinases and proteins together to form complexes, thereby regulating signal transduction process and various cellular biological processes, including cell cycle regulation, differentiation, and immune response. However, the function and mechanism of RACK1 in cervical Cancer remain incompletely understood. Here we identified that RACK1 could significantly suppress cell Ferroptosis in cervical Cancer cells. Mechanistically, RACK1 increased the expression of FUT8 by inhibiting miR-1275, which in turn promoted the FUT8-catalyzed core-fucosylation of cystine/glutamate antiporter SLC7A11, thereby inhibiting SLC7A11 degradation and cell Ferroptosis. Our data highlight the role of RACK1 in cervical Cancer progression and its suppression of Ferroptosis via the RACK1/miR-1275/FUT8/SLC7A11 axis, suggesting that inhibiting this pathway may be a promising therapeutic approach for patients with cervical Cancer.

Cervical cancer; Core-fucosylation; Ferroptosis; RACK1; SLC7A11; miRNA-1275.